Drug Type Synthetic peptide |
Synonyms RAY 002, RAY 1225, RAY-002 + [2] |
Target |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 3 | China | 15 Jun 2025 | |
Diabetes Mellitus, Type 2 | Phase 2 | China | 26 Feb 2024 | |
Nonalcoholic Steatohepatitis | Phase 2 | China | - | |
Chronic Kidney Diseases | Phase 1 | China | 11 Sep 2024 | |
Hepatic Insufficiency | Phase 1 | China | 26 Aug 2024 | |
Liver Injury | Phase 1 | China | 26 Aug 2024 |
SHINING-1 (NEWS) Manual | Phase 2 | - | RAY1225 3mg | zllatslyzc(vfcnmqytdk) = dkvrcwxkvr lifpeaffay (fjhnnutreq ) Met View more | Positive | 31 Dec 2024 | |
RAY1225 6mg | zllatslyzc(vfcnmqytdk) = ghkbyoedkn lifpeaffay (fjhnnutreq ) Met View more | ||||||
REBUILDING-1 (NEWS) Manual | Phase 2 | 122 | RAY1225注射液 3mg | hrqpolbrru(fbruoopxea) = delggbozvt xtkpnkqzfb (ncjkkxaosf ) View more | Positive | 21 Nov 2024 | |
RAY1225注射液 6mg | hrqpolbrru(fbruoopxea) = tgpbqhvnpc xtkpnkqzfb (ncjkkxaosf ) View more |